Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market
CANCER CHEMOTHERAPY ASSOCIATED NAUSEA AND VOMITING THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type (Acute CINV, Delayed CINV, Anticipatory nausea and emesis and Breakthrough CINV/Refractory CINV), By Drug Class (Dopamine Receptor Antagonists (Metoclopramide, Chlorpromazine, Prochlorperazine, Haloperidol, Droperidol and Others), Serotonin (5-HT3) receptor Antagonists (Ondansetron, Granisetron, Palonosetron, Dolasetron and others), Substance P/NK-1 Antagonists (Aprepitant, Fosaprepitant, Netupitant, and Others), Corticosteroids (Dexamethasone and Methylprednisolone) and others), By Route of Administration (Oral, Parenteral and Transdermal Patch), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
- Published In: 29 Apr, 2026
- Code: CMI5823
- Page number: 266
- Formats: Excel and PDF
- Industry: Pharmaceutical
-
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033
Table of Contents (Version-2026)
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- PEST Analysis
- PORTER’s Analysis
- Regulatory Scenario
- Merger, Collaboration and Acquisition Scenario
- Product Launches/Approvals
- Epidemiology
- Market Dynamics
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Acute CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Delayed CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Anticipatory nausea and emesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Breakthrough CINV/Refractory CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Drug Class, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Dopamine Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Metoclopramide
- Chlorpromazine
- Prochlorperazine
- Haloperidol
- Droperidol
- Others
- Serotonin (5-HT3) receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Ondansetron
- Granisetron
- Palonosetron
- Dolasetron
- Others
- Substance P/NK-1 Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Aprepitant
- Fosaprepitant
- Netupitant
- Others
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Dexamethasone
- Methylprednisolone
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Transdermal Patch
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region, 2021 – 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022–2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
Competitive Landscape
- Eisai Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharmanovia
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Helsinn Healthcare SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reddy’s Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Validus Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LGM Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AdvaCare Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Norgine
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PV Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hetero Healthcare Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biopharmaceutical Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Otsuka Pharmaceutical Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Weefsel Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rosemont Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Starton Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Co., Ltd.
Section
- Research Methodology
- About Us
*Browse 45 market data tables and 39 figures on "Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market” - forecast to 2033
-
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
